WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2013044865) OXAZOLIDINONE ANTIBIOTICS CONTAINING FUSED RING
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2013/044865    International Application No.:    PCT/CN2012/082422
Publication Date: 04.04.2013 International Filing Date: 29.09.2012
IPC:
C07D 413/14 (2006.01), C07D 498/04 (2006.01), C07D 487/04 (2006.01), C07D 495/04 (2006.01), C07D 491/048 (2006.01), C07D 513/04 (2006.01), A61K 31/422 (2006.01), A61K 31/429 (2006.01), A61K 31/424 (2006.01), A61P 31/04 (2006.01)
Applicants: XUANZHU PHARMA CO., LTD. [CN/CN]; 2518, Tianchen Street, National High-Tech Development Zone Jinan, Shandong 250101 (CN)
Inventors: ZHANG, Hui; (CN).
WANG, Aichen; (CN)
Agent: BEIJING HANSENSE LAW FIRM; 11/F., Bldg. D, International Finance and Economics Center No. 87, West 3rd Ring North Rd., Haidian District Beijing 100089 (CN)
Priority Data:
201110291417.4 30.09.2011 CN
Title (EN) OXAZOLIDINONE ANTIBIOTICS CONTAINING FUSED RING
(FR) ANTIBIOTIQUES OXAZOLIDINONES CONTENANT UN CYCLE FUSIONNÉ
(ZH) 含有并环的噁唑烷酮类抗菌素
Abstract: front page image
(EN)The present invention relates to an oxazolidinone antibiotics compound containing a fused ring represented by General Formula (I), pharmaceutically acceptable salts thereof, and stereoisomers thereof. The definition of R1, R2, R3, R4, R5, R6, A, B and C is the same as that in the specification. The present invention also relates to the preparation method of the compounds, a medicine composition and a pharmaceutical preparation that comprise these compounds, and applications of these compounds in preparing medicine for treating/preventing infectious diseases and in treating/preventing infectious diseases.
(FR)L'invention cioncerne un composé antibiotique oxazolidinone contenant un cycle fusionné représenté par la Formule Générale (I), des sels pharmaceutiquement acceptables de celui-ci et des stéréo-isomères de celui-ci. La définition de R1, R2, R3, R4, R5, R6, A, B et C est la même que dans la description. La présente invention concerne également un procédé de préparation des composés, une composition de médicament et une préparation pharmaceutique qui comprend ces composés, et des applications de ces composés dans la préparation d'un médicament pour le traitement/la prévention de maladies infectieuses et dans le traitement/la prévention de maladies infectieuses.
(ZH)本发明涉及通式(I)所示的含有并环的噁唑烷酮类化合物、其药学上可接受的盐以及它们的立体异构体,其中R1、R2、R3、R4、R5、R6、A、B和C的定义同说明书中所述定义;本发明还涉及这些化合物的制备方法,含有这些化合物的药物组合物和药物制剂,以及这些化合物在制备治疗和/或预防感染性疾病的药物和治疗和/或预防感染性疾病方面的应用。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)